- Home
- ALDX vs MYTE Comparison
ALDX vs MYTE Comparison
Compare ALDX & MYTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- MYTE
- Stock Information
- Founded
- ALDX 2004
- MYTE 2006
- Country
- ALDX United States
- MYTE Germany
- Employees
- ALDX N/A
- MYTE N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- MYTE Catalog/Specialty Distribution
- Sector
- ALDX Health Care
- MYTE Consumer Discretionary
- Exchange
- ALDX Nasdaq
- MYTE Nasdaq
- Market Cap
- ALDX 319.4M
- MYTE 327.4M
- IPO Year
- ALDX 2014
- MYTE 2021
- Fundamental
- Price
- ALDX $4.85
- MYTE $6.94
- Analyst Decision
- ALDX Strong Buy
- MYTE Buy
- Analyst Count
- ALDX 2
- MYTE 2
- Target Price
- ALDX $10.00
- MYTE $4.88
- AVG Volume (30 Days)
- ALDX 571.6K
- MYTE 142.3K
- Earning Date
- ALDX 11-07-2024
- MYTE 11-19-2024
- Dividend Yield
- ALDX N/A
- MYTE N/A
- EPS Growth
- ALDX N/A
- MYTE N/A
- EPS
- ALDX N/A
- MYTE N/A
- Revenue
- ALDX N/A
- MYTE $953,698,416.00
- Revenue This Year
- ALDX N/A
- MYTE $11.82
- Revenue Next Year
- ALDX $25.36
- MYTE $11.78
- P/E Ratio
- ALDX N/A
- MYTE N/A
- Revenue Growth
- ALDX N/A
- MYTE 9.55
- 52 Week Low
- ALDX $2.43
- MYTE $2.41
- 52 Week High
- ALDX $6.55
- MYTE $8.24
- Technical
- Relative Strength Index (RSI)
- ALDX 45.59
- MYTE 59.37
- Support Level
- ALDX $4.66
- MYTE $6.01
- Resistance Level
- ALDX $5.01
- MYTE $7.34
- Average True Range (ATR)
- ALDX 0.40
- MYTE 0.40
- MACD
- ALDX -0.01
- MYTE 0.04
- Stochastic Oscillator
- ALDX 46.06
- MYTE 69.78
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About MYTE MYT Netherlands Parent B.V. each representing one
MYT Netherlands Parent BV is a luxury e-commerce platform. The company offers luxury fashion wear for men, women, and kids. Also, the company sells shoes, bags, and accessories. The company operates in two segments which include the online segment and Retail store segments in which the majority of its revenue is generated from the Online segment.